Sientra (SIEN) Revenue & Revenue Breakdown
Sientra Revenue Highlights
Latest Revenue (Y)
$90.55M
Latest Revenue (Q)
$19.54M
Main Segment (Y)
Breast Product
Main Geography (Y)
North America
Sientra Revenue by Period
Sientra Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2022-12-31 | $90.55M | 12.23% |
| 2021-12-31 | $80.68M | 13.25% |
| 2020-12-31 | $71.24M | -14.88% |
| 2019-12-31 | $83.70M | 22.86% |
| 2018-12-31 | $68.13M | 86.43% |
| 2017-12-31 | $36.54M | 76.24% |
| 2016-12-31 | $20.73M | -45.59% |
| 2015-12-31 | $38.11M | -14.81% |
| 2014-12-31 | $44.73M | 27.19% |
| 2013-12-31 | $35.17M | 236.66% |
| 2012-12-31 | $10.45M | - |
Sientra generated $90.55M in revenue during NA 2022, up 12.23% compared to the previous quarter, and up 247.79% compared to the same period a year ago.
Sientra Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2023-09-30 | $19.54M | -15.50% |
| 2023-06-30 | $23.13M | 2.54% |
| 2023-03-31 | $22.56M | -10.02% |
| 2022-12-31 | $25.07M | 11.07% |
| 2022-09-30 | $22.57M | 4.91% |
| 2022-06-30 | $21.51M | 0.54% |
| 2022-03-31 | $21.40M | -5.52% |
| 2021-12-31 | $22.65M | 15.43% |
| 2021-09-30 | $19.62M | -2.40% |
| 2021-06-30 | $20.10M | -13.48% |
| 2021-03-31 | $23.24M | 2.61% |
| 2020-12-31 | $22.64M | 17.83% |
| 2020-09-30 | $19.22M | 54.38% |
| 2020-06-30 | $12.45M | -26.48% |
| 2020-03-31 | $16.93M | -27.05% |
| 2019-12-31 | $23.21M | 3.56% |
| 2019-09-30 | $22.41M | 9.19% |
| 2019-06-30 | $20.52M | 16.94% |
| 2019-03-31 | $17.55M | -7.73% |
| 2018-12-31 | $19.02M | 12.72% |
| 2018-09-30 | $16.88M | -3.87% |
| 2018-06-30 | $17.55M | 19.61% |
| 2018-03-31 | $14.68M | 32.63% |
| 2017-12-31 | $11.06M | 12.69% |
| 2017-09-30 | $9.82M | 20.20% |
| 2017-06-30 | $8.17M | 9.08% |
| 2017-03-31 | $7.49M | 15.43% |
| 2016-12-31 | $6.49M | -0.66% |
| 2016-09-30 | $6.53M | 4.60% |
| 2016-06-30 | $6.24M | 324.47% |
| 2016-03-31 | $1.47M | -4.29% |
| 2015-12-31 | $1.54M | -84.52% |
| 2015-09-30 | $9.93M | -30.11% |
| 2015-06-30 | $14.21M | 14.25% |
| 2015-03-31 | $12.43M | 2.62% |
| 2014-12-31 | $12.12M | 13.55% |
| 2014-09-30 | $10.67M | -8.95% |
| 2014-06-30 | $11.72M | 14.58% |
| 2014-03-31 | $10.23M | 10.57% |
| 2013-12-31 | $9.25M | 15.90% |
| 2013-09-30 | $7.98M | - |
Sientra generated $19.54M in revenue during Q3 2023, up -15.50% compared to the previous quarter, and up 90.85% compared to the same period a year ago.
Sientra Revenue Breakdown
Sientra Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|
| Breast Product | $55.00M | $46.36M | $37.02M |
| Miradry | $16.24M | $37.34M | $31.11M |
Sientra's latest annual revenue breakdown by segment (product or service), as of Dec 20: Breast Product (77.20%), and Miradry (22.80%).
Quarterly Revenue by Product
| Product/Service | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast Product | $18.31M | $17.89M | $15.33M | $9.31M | $12.47M | $12.79M | $12.63M | $11.19M | $9.75M | $10.45M | $8.61M | $9.41M | $8.54M |
| Miradry | $4.92M | $4.76M | $3.89M | $3.14M | $4.46M | $10.42M | $9.79M | $9.33M | $7.80M | $8.57M | $8.26M | $8.14M | $6.13M |
Sientra's latest quarterly revenue breakdown by segment (product or service), as of Mar 21: Breast Product (78.81%), and Miradry (21.19%).
Sientra Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 22 | Dec 21 | Dec 20 | Dec 19 | Dec 18 |
|---|---|---|---|---|---|
| Non-US | $2.44M | $1.65M | - | - | - |
| North America | $88.10M | $79.04M | $58.75M | $62.28M | $49.98M |
| Non Us | - | - | $12.49M | $21.42M | $18.15M |
Sientra's latest annual revenue breakdown by geography, as of Dec 22: North America (97.30%), and Non-US (2.70%).
Quarterly Revenue by Country
| Country | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Dec 18 | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Breast Product | $18.31M | $17.89M | $15.33M | $9.31M | $12.47M | $12.79M | $12.63M | $11.19M | $9.75M | $10.45M | $8.61M | $9.41M | $8.54M |
| Miradry | $4.92M | $4.76M | $3.89M | $3.14M | $4.46M | $10.42M | $9.79M | $9.33M | $7.80M | $8.57M | $8.26M | $8.14M | $6.13M |
Sientra's latest quarterly revenue breakdown by geography, as of Mar 21: Breast Product (78.81%), and Miradry (21.19%).
Sientra Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ITGR | Integer | $1.60B | $753.01M |
| AVNS | Avanos Medical | $673.30M | $171.70M |
| ATEC | Alphatec | $482.26M | $42.98M |
| AORT | Artivion | $354.00M | $98.02M |
| INGN | Inogen | $315.66M | $88.77M |
| FNA | Paragon 28 | $216.39M | $61.02M |
| ANIK | Anika Therapeutics | $166.66M | $41.92M |
| AXGN | AxoGen | $159.01M | $47.91M |
| SRDX | Surmodics | $132.58M | $30.34M |
| SIEN | Sientra | $90.55M | $19.54M |
| SGHT | Sight Sciences | $81.06M | $21.37M |
| LUNG | Pulmonx | $68.67M | $20.78M |
| NPCE | NeuroPace | $65.42M | $18.12M |
| APYX | Apyx Medical | $52.35M | $12.15M |
| LNSR | LENSAR | $42.16M | $10.59M |
| CVRX | CVRx | $39.30M | $11.81M |
| SSKN | STRATA Skin Sciences | $33.36M | $8.44M |
| VVOS | Vivos Therapeutics | $13.80M | $4.05M |
| AIMD | Ainos | $122.11K | - |
| OFIX | Orthofix Medical | $100.00K | $198.62M |
SIEN Revenue FAQ
What is Sientra’s yearly revenue?
Sientra's yearly revenue for 2022 was $90.55M, representing an increase of 12.23% compared to 2021. The company's yearly revenue for 2021 was $80.68M, representing an increase of 13.25% compared to 2020. SIEN's yearly revenue for 2020 was $71.24M, representing a decrease of -14.88% compared to 2019.
What is Sientra’s quarterly revenue?
Sientra's quarterly revenue for Q3 2023 was $19.54M, a -15.50% decrease from the previous quarter (Q2 2023), and a -13.41% decrease year-over-year (Q3 2022). The company's quarterly revenue for Q2 2023 was $23.13M, a 2.54% increase from the previous quarter (Q1 2023), and a 7.52% increase year-over-year (Q2 2022). SIEN's quarterly revenue for Q1 2023 was $22.56M, a -10.02% decrease from the previous quarter (Q4 2022), and a 5.42% increase year-over-year (Q1 2022).
What is Sientra’s revenue growth rate?
Sientra's revenue growth rate for the last 3 years (2020-2022) was 27.10%, and for the last 5 years (2018-2022) was 32.91%.
What are Sientra’s revenue streams?
Sientra's revenue streams in c 20 are Breast Product, and Miradry. Breast Product generated $55M in revenue, accounting 77.20% of the company's total revenue, up 18.62% year-over-year. Miradry generated $16.24M in revenue, accounting 22.80% of the company's total revenue, down -56.49% year-over-year.
What is Sientra’s main source of revenue?
For the fiscal year ending Dec 20, the largest source of revenue of Sientra was Breast Product. This segment made a revenue of $55M, representing 77.20% of the company's total revenue.